[2018 new recommendations for dyslipidemia : a critical review of evidence].

Dyslipidemia is an important cardiovascular risk factor. Its management should be individualized according to cardiovascular risk, which can be estimated using PROCAM score, taking into account patients' comorbidities. Cardiovascular risk is classified as low, moderated or high. The Swiss Atherosclerosis Association (AGLA) recently published new recommendations that we are describing taking into account evidence of recent studies, in order to avoid overmedicalisation. Lifestyle interventions should always be implemented and are the main therapy for most patients in primary prevention. A secondary etiology should be excluded, as its treatment can often normalize the lipid disturbance. Familial dyslipidemia should be looked for, as it is associated with a particularly high cardiovascular risk, and because of its specific management.